Copyright
©The Author(s) 2015.
World J Nephrol. May 6, 2015; 4(2): 169-184
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.169
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.169
Figure 1 Representation of the classical, lectin and alternative pathways of complement activation, including regulatory molecules (purple).
MBL: Mannose binding lectin; MASP 1/2: Mannan-binding lectin-associated serine protease-1; C1INH: C1 inhibitor; DAF: Decay accelerating factor; CR-1: Complement receptor 1; MCP: Membrane co-factor protein.
- Citation: Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol 2015; 4(2): 169-184
- URL: https://www.wjgnet.com/2220-6124/full/v4/i2/169.htm
- DOI: https://dx.doi.org/10.5527/wjn.v4.i2.169